Human Immunodeficiency Virus 2 (HIV-2) DNA/RNA Qualitative or Quantitative
The Human Immunodeficiency Virus (HIV) exists in two genetically distinct forms: HIV-1 and HIV-2. The most common type is HIV-1 which is present in 95% of infected patients. HIV-2 is endemic in most regions of Western Africa, however, its prevalence in other parts of the world has been rising.
HIV-2 is clinically distinct from HIV-1 due to its low transmission rate, slower progression, low replication rate, and resistance to reverse transcriptase inhibitors. This has mandated a different patient monitoring approach compared to HIV-1 infection. HIV-2 is typically diagnosed using current fourth generation HIV1/HIV2 antibody assays. Patients positive for HIV-2 antibodies should have HIV-2 infection confirmed with either HIV-2 specific western blot, HIV-2 specific enzyme immunoassay or RT-PCR for HIV-2 genetic markers. RT-PCR testing involves the amplification of the gag gene and long terminal repeats (LTRs) of the HIV-2 genome. The test offers a good specificity of 100% and sensitivity with a detection limit of 5 copies per mL.
- As an aid in diagnosis of HIV-2 infection
- Monitoring and management of HIV-2 infection
Not detected
Whole blood (EDTA).
Stability
- Ambient: 7 days
- Refrigerated: 14 days
- Frozen: 30 days
- AIDS. 2001;15 Suppl 5:S35-45. [PMID: 11816173]
- J Clin Microbiol. 2017 Sep;55(9):2850-2857. [PMID: 28701422]
- Jpn J Infect Dis. 2016 Sep 21;69(5):367-72. [PMID: 26743143]
- Infect Genet Evol. 2016 Dec;46:233-240 [PMID: 27530215]
- J Clin Virol. 2001 Jun;21(3):187-96 [PMID: 11397655]
- HIV-2 Infection. [Updated 2022 Sep 20]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan